» Authors » Hector Contreras

Hector Contreras

Explore the profile of Hector Contreras including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 128
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gastelbondo-Pastrana B, Florez L, Guzman C, Torres K, Garay E, Ballesteros-Villamizar J, et al.
J Virol Methods . 2025 Feb; 334:115116. PMID: 39956397
During the COVID-19 pandemic, reagents for SARS-CoV-2 detection were scarce or sold at high prices, particularly in Latin America. In this study, a significant step towards self-sufficiency was achieved through...
2.
Olivares-Caro L, Nova-Baza D, Sanhueza F, Contreras H, Alarcon B, Alarcon-Zapata P, et al.
Anal Bioanal Chem . 2024 Dec; PMID: 39714519
Coronavirus disease 2019 is a highly contagious respiratory illness caused by the coronavirus SARS-CoV-2. Symptoms can range from mild to severe and typically appear 2-14 days after virus exposure. While...
3.
Moreno A, Alarcon-Zapata P, Guzman-Gutierrez E, Radojkovic C, Contreras H, Nova-Lampeti E, et al.
Biomedicines . 2024 Sep; 12(9). PMID: 39335632
Acute myocardial infarction (AMI) results from vulnerable plaque rupture, causing ischemic cardiomyocyte necrosis and intense inflammation. Paradoxically, this inflammation releases factors that aid heart repair. Recent findings suggest a role...
4.
Lopez Y, Thomas R, Munoz-Leal S, Lopez-Mejia Y, Galeano K, Garcia A, et al.
Parasit Vectors . 2024 Jun; 17(1):268. PMID: 38918818
Background: Ticks are obligate hematophagous ectoparasites involved in transmitting viruses of public health importance. The objective of this work was to identify the Jingmen tick virus in hard ticks from...
5.
Alarcon-Zapata P, Perez A, Toledo-Onate K, Contreras H, Ormazabal V, Nova-Lamperti E, et al.
Life Sci . 2023 Oct; 333:122166. PMID: 37827232
Ovarian cancer presents a significant challenge due to its high rate of chemoresistance, which complicates the effectiveness of drug-response therapy. This study provides a comprehensive metabolomic analysis of ovarian cancer...
6.
Martinez C, Serrano-Coll H, Faccini A, Contreras V, Galeano K, Botero Y, et al.
BMC Infect Dis . 2022 Jul; 22(1):644. PMID: 35883062
Background: The ability of SARS-CoV-2 to remain in asymptomatic individuals facilitates its dissemination and makes its control difficult. Objective: To establish a cohort of asymptomatic individuals, change to the symptomatic...
7.
Garay E, Serrano-Coll H, Rivero R, Gastelbondo B, Faccini-Martinez A, Berrocal J, et al.
Trans R Soc Trop Med Hyg . 2021 Jun; 116(2):139-147. PMID: 34185868
Background: Serological evaluation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an alternative that allows us to determine the prevalence and dynamics of this infection in populations. The goal...
8.
Contreras H, Vallejo A, Mattar S, Ruiz L, Guzman C, Calderon A
Vet World . 2021 Jun; 14(4):865-872. PMID: 34083933
Background And Aim: In 2016, the tilapia-producing farms in the department of Córdoba, Colombia, had witnessed outbreaks of disease with clinical signs compatible with those caused by the tilapia lake...
9.
Mattar S, Alvis-Guzman N, Garay E, Rivero R, Garcia A, Botero Y, et al.
Open Forum Infect Dis . 2020 Dec; 7(12):ofaa550. PMID: 33354587
A serological survey was carried out in Monteria (500 000 population), a mid-size city in Colombia. An overall prevalence of 55.3% (95% confidence interval, 52.5%-57.8%) was found among a sample...
10.
Mattar S, Martinez-Bravo C, Rivero R, Contreras H, Faccini-Martinez A, Guzman-Teran C, et al.
Ann Clin Microbiol Antimicrob . 2020 Dec; 19(1):58. PMID: 33287846
Background: Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) is an emerging viral pandemic disease. In the last 6 months, SARS-CoV-2 has caused millions of reported cases and hundreds of thousands...